Greenwich LifeSciences Inc Gains 38.98%
Tue, Jul 12, 2022 at 08:30 PM
Greenwich LifeSciences Inc (GLSI:NASDAQ) shot up at $11.98, representing a gain of 39%. On Tue, Jul 12, 2022, GLSI:NASDAQ touched a New 2-Week High of $11.98. The stock got featured on our News Catalysts scanner on Tue, Jul 12, 2022 at 06:37 AM in the 'BIOTECH' category. From Tue, Jun 28, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About Greenwich LifeSciences Inc (GLSI:NASDAQ)
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Top 10 Gainers:
- Sharps Compliance Corp. (SMED:NASDAQ), 196.14%
- Canoo Inc. (GOEV:NASDAQ), 53.16%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 42.22%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 38.98%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 36.88%
- China Online Education Group (COE:NYSE), 32.84%
- Histogen Inc. (HSTO:NASDAQ), 27.46%
- Romeo Power Inc. Class A (RMO:NYSE), 26%
- Lucira Health Inc. (LHDX:NASDAQ), 24.28%
- Aclarion Inc. (ACON:NASDAQ), 22.86%